Brainscope

Miles R. Gilburne

Chairman of the Board of the Directors

An accomplished senior executive, Miles Gilburne has more than twenty-five years of experience in mergers and acquisitions, corporate strategy, venture capital and technology law. From 1994 to 1999, he served as Senior Vice President of Corporate Development of America Online (AOL), where he was responsible for strategic planning and major corporate acquisitions, joint ventures and alliances. He served as a Director of America Online from 1999 until the AOL/Time Warner merger in January 2001 and continued to serve on the board of Time Warner, Inc. until resigning in May 2006. He currently serves on the board of directors of SRA, Inc., a publicly traded provider of technology and services to government markets, Pharmacyclics, Inc., a publicly traded drug discovery company, and several privately held technology and media companies. Prior to joining AOL, Gilburne was a founding partner of The Cole Gilburne Fund, an early stage venture capital fund, and a founding partner of technology and media law firms in San Francisco and Los Angeles. He is currently a managing member of ZG Ventures, LLC, a private investment firm.

Mr. Gilburne holds a Bachelor of Arts degree from Princeton University and a law degree from Harvard University. He serves on the boards of Pharmacyclics, Inc. and Revolution Health Group. He is also a member of the board of directors of the Foundation for the National Institutes of Health. Mr. Gilburne is a co-chairman of ePALS, a Washington, DC-based company that creates and distributes learning programs and services, as well as a suite of collaborative technologies designed for K-12 school and home markets.

Moshe Alafi

Moshe Alafi, has been called one of the founders of biotechnology, as he was one of the first venture capitalists to see the exciting potential in biotechnology. He has been an active investor for over twenty-five years, and was a seed investor in Cetus, Biogen, Applied Biosystems, and Amgen. He has founded over 60 companies throughout his career. Alafi Capital is a private venture capital firm that has been active in healthcare investing in early and mid-stage investments in the U.S. and Europe, with emphasis on product-oriented biotechnology, life science technologies, imaging and diagnostics, and medical devices.

Jean Case

Jean Case is CEO of the Case Foundation, which she and her husband, AOL co-founder Steve Case, created in 1997. Jean spent her early days at the Case Foundation doing a deep-dive into philanthropy and seeking the best ways she could make a difference. Prior to co-founding the Case Foundation, Jean was a technology executive in the private sector. As a senior executive at America Online, Inc. (AOL), Jean directed the marketing and branding effort that launched the AOL service, directed the communications strategy for taking the company public, and helped establish AOL as a household utility. Before joining the company when it was a small startup, she held strategic marketing positions at GE's Information Services Division and at The Source, the nation's first online service. We're pretty sure these early experiences played a role in making Jean a big fan of all things digital and the amazing potential of technology to change the world for the better. In addition to her role as CEO of the Case Foundation, Jean has served in two appointed roles leading strategic public-private efforts, including chair of the President's Council on Service and Civic Participation and co-chair of the U.S.-Palestinian Partnership.

John M. Reher

John M. Reher created the Brain Trust Accelerator Fund in 2006. The goal of this venture capital fund is to earn an attractive rate of return by creating and investing in early-stage medical companies that address brain-related diseases. The general partner of the fund donates a portion of its management fee and the carried interest to brain disease charities, which provide deal flow and advisory services. Current investments include Amnestix (sold to Sygnis Pharma), Neurofluidics and Satoris.

He was founding president and executive director of Accelerate Brain Cancer Cure, Inc. (ABC2) from 2001-2006. ABC2 is a non-profit organization dedicated to accelerating therapies for treatment of brain cancer by employing venture principles to this philanthropic endeavor.

Mr. Reher previously had over 12 years of venture capital experience as a general partner and co-founder of Medicus Venture Partners, an early-stage healthcare venture partnership with investments including Biosite Diagnostics, Inhale Therapeutic Systems (now Nektar), Tularik, and other successful companies.

Before entering the venture industry in 1989, Mr. Reher held financial, marketing, licensing, acquisitions and overall team leader positions for Genentech (1982-1989) and G.D. Searle Pharmaceuticals (1974-1981).

Mr. Reher has taught college courses in Economics, Finance and Investments. He received a Masters of Management degree from Northwestern University and a B.S. in Mathematics and Business Economics from Illinois Benedictine University.

James Peake, M.D.

James Peake was United States Secretary of Veterans Affairs from 2007 to 2009. In 2004, he retired from a 42-year United States Army career. He also served as the 40th Surgeon General of the United States Army. Peake received his Bachelor of Science degree from U.S. Military Academy at West Point in 1966 and was commissioned a second lieutenant in the U.S. Army Infantry. He served in Vietnam with the 101st Airborne Division where he was awarded the Silver Star, a Bronze Star with “V” device and the Purple Heart with oak leaf cluster. Following his service in Vietnam, he attended Cornell University’s Weill Cornell Medical College, and was awarded a medical doctorate in 1972. He is also a graduate of the United States Army War College, in 1988. He retired from the Army in 2004, as a Lieutenant General.

Dr. Peake served for four years as the United States Army Surgeon General. He also served as commander of several Army medical units. Previous key assignments include Commander, U.S. Army Medical Department Center and School and Installation Commander, Fort Sam Houston, Texas; Deputy Commander, U.S. Army Medical Command, Fort Sam Houston, Texas; Commanding General, Madigan Army Medical Center/Northwest Health Service Support Activity, Tacoma, Washington; Commanding General, 44th Medical Brigade/Corps Surgeon, XVIII Airborne Corps, Fort Bragg, North Carolina; Deputy Director, Professional Services/Chief, Consultant, Office of the Surgeon General, Falls Church, Virginia; Commander, 18th Medical Command and 121st Evacuation Hospital/Command Surgeon, Seoul, Korea; Deputy Commander for Clinical Services, Tripler Army Medical Center, Honolulu, Hawaii; Assistant Chief, Cardiothoracic Surgery, Brooke Army Medical Center, Fort Sam Houston, Texas; Staff General Surgeon/Chief, General Surgery Clinic, DeWitt Army Hospital, Fort Belvoir, Va.; and General Surgery Resident, Brooke Army Medical Center, Fort Sam Houston, Texas.

After retiring from the Army, Dr. Peake served as Executive Vice President and Chief Operating Officer of Project Hope, a non-profit international health foundation operating in more than 30 countries. While at Project HOPE he helped to orchestrate the use of civilian volunteers aboard the Navy Hospital Ship Mercy as it responded to the Tsunami disaster in Indonesia and also as part of the Hurricane Katrina response aboard the Hospital Ship Comfort.

Gail Wilensky, Ph.D

Gail Wilensky is an economist and a senior fellow at Project HOPE, an international health education foundation. She serves as a trustee of the Combined Benefits Fund of the United Mineworkers of America and the National Opinion Research Center, is on the Board of Regents of the Uniformed Services University of the Health Sciences (USUHS) and the Visiting Committee of Harvard Medical and Dental Schools. She recently served as president of the Defense Health Board and chaired their Health care Subcommittee, was a commissioner on the World Health Organization’s Commission on the Social Determinants of Health and co-chaired the Dept. of Defense Task Force on the Future of Military Health Care.

She is an elected member of the Institute of Medicine and has served two terms on its governing council. She is a former chair of the board of directors of Academy Health, a former trustee of the American Heart Association and a current or former director of numerous other non-profit organizations. She is also a director on several corporate boards. From 1990-1992, she was Administrator of the Health Care Financing Administration (now known as CMS), directing the Medicare and Medicaid programs. She also served as Deputy Assistant to President (GHW) Bush for Policy Development, advising him on health and welfare issues from 1992-1993.

From 1997-2001, she chaired the Medicare Payment Advisory Commission, which advises Congress on payment and other issues relating to Medicare and previously chaired one of its predecessor commissions, the Physician Payment Review Commission. From 2001 to 2003, she co-chaired the President’s Task Force to Improve Health Care Delivery for Our Nation’s Veterans and in 2007, served as a Commissioner on the President’s Commission on Care for America’s Returning Wounded Warriors (Dole/Shalala Commission).

Dr. Wilensky testifies frequently before Congressional committees, serves as an advisor to members of Congress and other elected officials, speaks nationally and internationally before professional, business and consumer groups. She received a bachelor’s degree in psychology and a Ph.D. in economics at the University of Michigan and has received several honorary degrees.

Michael Singer

Michael Singer is the CEO of BrainScope.